Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$27,748,815
+$840,024 QoQ
Shares Held
23,135
-20.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#745
of 4,605 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CenterBook Partners LP holds $48,546,896 across 5 Drug Manufacturers - General names. LLY ranks #1 (57.2% of the industry book) .
All Filings in LLY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,748,815 | 23,135 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $26,908,791 | 29,256 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $26,298,496 | 24,471 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $26,772,957 | 34,345 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $14,904,232 | 19,306 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,846,298 | 2,084 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,888,575 | 8,713 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,369,936 | 8,188 | Shares | Sole | 2024-05-10 | |
| 2023-09-30 | $1,598,498 | 2,976 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,785,875 | 3,808 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,287,864 | 6,662 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,845,869 | 7,779 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,619,983 | 5,010 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,200,549 | 6,787 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||